The attachment of recognition elements such as antibody fragments to polymeric substrates can be used to mediate cell- or protein-specific interactions. In this work, single-chain Fv (scFv) antibody fragments were isolated against two cell types of interest and expressed in an Escherichia coli expression platform. The scFvs were engineered at their C-terminus to incorporate a cysteine-containing linker, for reaction with maleimide-linked polymers, or a heptasaccharide glycan for complexation with surface amine moieties. Antigen binding of the modified scFvs was unchanged, and expression yields of the glyco-engineered scFvs were similar to the unmodified molecules, while cys-tagged scFv yields varied between scFv variants. Targeted immobiliz...
A Fab-like antibody binding unit, ccFv, in which a pair of heterodimeric coiled-coil domains was fus...
In recent years, phage display of peptides and proteins has become a very popular method in oncology...
148 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1999.Mutants of anti-fluorescein s...
Single chain variable fragment (scFv) molecules were selected from a synthetic phage display library...
AbstractProtein engineering allows the generation of hybrid polypeptides with functional domains fro...
AbstractThe ability to design and tailor-make antibodies to meet the biophysical demands required by...
Antibody fragments are used in the clinic as important therapeutic proteins for treatment of indicat...
The hypervariable loops of an antibody molecule are supported on the relatively conserved β-sheeted ...
The ability to design and tailor-make antibodies to meet the biophysical demands required by the vas...
Antibody-derived fragments have enormous potential application in solid-phase assays such as biomark...
The ability to design and tailor-make antibodies to meet the biophysical demands required by the vas...
With high affinity and specificity, antibodies are now proven biotherapuetics for a wide range of di...
The availability of cost-effective high throughput screening assays combined with an enhanced unders...
By constructing Fv and single-chain Fv (scFv) fragments of antibodies, the variable domains are take...
In the current study, we introduce a method to design intrinsically soluble single chain antibodies ...
A Fab-like antibody binding unit, ccFv, in which a pair of heterodimeric coiled-coil domains was fus...
In recent years, phage display of peptides and proteins has become a very popular method in oncology...
148 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1999.Mutants of anti-fluorescein s...
Single chain variable fragment (scFv) molecules were selected from a synthetic phage display library...
AbstractProtein engineering allows the generation of hybrid polypeptides with functional domains fro...
AbstractThe ability to design and tailor-make antibodies to meet the biophysical demands required by...
Antibody fragments are used in the clinic as important therapeutic proteins for treatment of indicat...
The hypervariable loops of an antibody molecule are supported on the relatively conserved β-sheeted ...
The ability to design and tailor-make antibodies to meet the biophysical demands required by the vas...
Antibody-derived fragments have enormous potential application in solid-phase assays such as biomark...
The ability to design and tailor-make antibodies to meet the biophysical demands required by the vas...
With high affinity and specificity, antibodies are now proven biotherapuetics for a wide range of di...
The availability of cost-effective high throughput screening assays combined with an enhanced unders...
By constructing Fv and single-chain Fv (scFv) fragments of antibodies, the variable domains are take...
In the current study, we introduce a method to design intrinsically soluble single chain antibodies ...
A Fab-like antibody binding unit, ccFv, in which a pair of heterodimeric coiled-coil domains was fus...
In recent years, phage display of peptides and proteins has become a very popular method in oncology...
148 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1999.Mutants of anti-fluorescein s...